EP300 and colorectal carcinoma: In summary, this research describes a novel SEMA3B‐AS1–EP300–SEMA3B–NRP1 axis and unravels the potential molecular mechanisms of lncRNA SEMA3B‐AS1 in CRC progression, providing novel ideas for the diagnosis and treatment of CRC.